SILO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
SILO is not a good buy right now for an impatient trader. The trend is still bearish (SMA_200 > SMA_20 > SMA_5 with a negatively expanding MACD histogram), and there are no strong catalysts, no proprietary buy signals, and weak/erratic fundamentals. Any pre-market spike looks more like a short-term bounce risk than a reliable reversal setup.
Trend/structure: Bearish. Moving averages are stacked bearishly (SMA_200 > SMA_20 > SMA_5), indicating persistent downside momentum across timeframes. Momentum: MACD histogram is negative (-0.00131) and expanding lower, confirming downside momentum is strengthening rather than stabilizing. RSI: RSI_6 = 34.44 (near the low end of neutral, close to oversold). This can support a bounce, but by itself it is not a confirmed trend reversal. Levels: Current price 0.3509 is just below the pivot (0.36). Key support sits at S1 0.334 then S2 0.318; resistance is R1 0.387 then R2 0.403. For an impatient entry, buying below the pivot with bearish momentum is unfavorable—risk of slipping into the 0.334/0.318 zone is meaningful. Statistical forward bias (pattern analogs): Expected drift is slightly negative over the next week (-2.37%) and month (-1.67%), aligning with the bearish technical picture.
Intellectia Proprietary Trading Signals
Pre-market is up +8.72%, which may attract short-term momentum traders.
Net loss improved YoY in 2025/Q3 (Net Income -1.11M, up 19.55% YoY), suggesting some cost/expense improvement versus last year.
Price is near support and RSI is low-ish, which can occasionally lead to dead-cat/oversold bounces.
No news in the recent week, so there is no clear event-driven reason for a sustainable upside move.
Technical trend remains bearish: negative/expanding MACD and bearish MA stack suggest rallies may get sold.
2025/Q3 quality is weak: EPS fell to -0.12 (down 45.45% YoY) and gross margin deteriorated sharply (negative), implying poor operating leverage.
Trading sentiment data shows no supportive accumulation: hedge funds neutral, insiders neutral.
Congress/influential trading: no recent data available to indicate sponsorship.
Latest quarter: 2025/Q3. Revenue increased to 18,025 (reported as 0.00% YoY change), so top-line growth is minimal/flat. Profitability: Net income improved YoY to -1,110,438 (still a loss). EPS worsened YoY to -0.12, and gross margin dropped to -14.77 (significantly worse), indicating weak unit economics and ongoing losses despite some net-loss improvement.
No analyst rating or price target updates were provided in the data, so there is no observable recent Wall Street trend to support a buy thesis. Without upgrades/targets or coverage momentum, the pro case is limited; the con case (weak fundamentals + bearish trend) dominates.
